303 related articles for article (PubMed ID: 33805904)
1. MAIT Cells: Partners or Enemies in Cancer Immunotherapy?
Cogswell DT; Gapin L; Tobin HM; McCarter MD; Tobin RP
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805904
[TBL] [Abstract][Full Text] [Related]
2. Human MAIT cells endowed with HBV specificity are cytotoxic and migrate towards HBV-HCC while retaining antimicrobial functions.
Healy K; Pavesi A; Parrot T; Sobkowiak MJ; Reinsbach SE; Davanian H; Tan AT; Aleman S; Sandberg JK; Bertoletti A; Sällberg Chen M
JHEP Rep; 2021 Aug; 3(4):100318. PubMed ID: 34377970
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis for Mucosal-Associated Invariant T cell recognition of MR1 proteins.
López-Sagaseta J; Dulberger CL; Crooks JE; Parks CD; Luoma AM; McFedries A; Van Rhijn I; Saghatelian A; Adams EJ
Proc Natl Acad Sci U S A; 2013 May; 110(19):E1771-8. PubMed ID: 23613577
[TBL] [Abstract][Full Text] [Related]
4. Mucosal-associated invariant T cells for cancer immunotherapy.
Li YR; Zhou K; Wilson M; Kramer A; Zhu Y; Dawson N; Yang L
Mol Ther; 2023 Mar; 31(3):631-646. PubMed ID: 36463401
[TBL] [Abstract][Full Text] [Related]
5. A molecular basis underpinning the T cell receptor heterogeneity of mucosal-associated invariant T cells.
Eckle SB; Birkinshaw RW; Kostenko L; Corbett AJ; McWilliam HE; Reantragoon R; Chen Z; Gherardin NA; Beddoe T; Liu L; Patel O; Meehan B; Fairlie DP; Villadangos JA; Godfrey DI; Kjer-Nielsen L; McCluskey J; Rossjohn J
J Exp Med; 2014 Jul; 211(8):1585-600. PubMed ID: 25049336
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Human Mucosal-associated Invariant T (MAIT) Cells.
Souter MNT; Loh L; Li S; Meehan BS; Gherardin NA; Godfrey DI; Rossjohn J; Fairlie DP; Kedzierska K; Pellicci DG; Chen Z; Kjer-Nielsen L; Corbett AJ; McCluskey J; Eckle SBG
Curr Protoc Immunol; 2019 Dec; 127(1):e90. PubMed ID: 31763790
[TBL] [Abstract][Full Text] [Related]
7. Insights Into Mucosal-Associated Invariant T Cell Biology From Studies of Invariant Natural Killer T Cells.
Garner LC; Klenerman P; Provine NM
Front Immunol; 2018; 9():1478. PubMed ID: 30013556
[TBL] [Abstract][Full Text] [Related]
8. MAIT, MR1, microbes and riboflavin: a paradigm for the co-evolution of invariant TCRs and restricting MHCI-like molecules?
Mondot S; Boudinot P; Lantz O
Immunogenetics; 2016 Aug; 68(8):537-48. PubMed ID: 27393664
[TBL] [Abstract][Full Text] [Related]
9. MAIT cell-MR1 reactivity is highly conserved across multiple divergent species.
Edmans MD; Connelley TK; Morgan S; Pediongco TJ; Jayaraman S; Juno JA; Meehan BS; Dewar PM; Maze EA; Roos EO; Paudyal B; Mak JYW; Liu L; Fairlie DP; Wang H; Corbett AJ; McCluskey J; Benedictus L; Tchilian E; Klenerman P; Eckle SBG
J Biol Chem; 2024 May; 300(6):107338. PubMed ID: 38705391
[TBL] [Abstract][Full Text] [Related]
10. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries.
Corbett AJ; Awad W; Wang H; Chen Z
Front Immunol; 2020; 11():1961. PubMed ID: 32973800
[TBL] [Abstract][Full Text] [Related]
11. The Role of Mucosal Associated Invariant T Cells in Antimicrobial Immunity.
Napier RJ; Adams EJ; Gold MC; Lewinsohn DM
Front Immunol; 2015; 6():344. PubMed ID: 26217338
[TBL] [Abstract][Full Text] [Related]
12. MAIT Cells Come to the Rescue in Cancer Immunotherapy?
Lukasik Z; Elewaut D; Venken K
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32053875
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into MR1-mediated recognition of the mucosal associated invariant T cell receptor.
Reantragoon R; Kjer-Nielsen L; Patel O; Chen Z; Illing PT; Bhati M; Kostenko L; Bharadwaj M; Meehan B; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J
J Exp Med; 2012 Apr; 209(4):761-74. PubMed ID: 22412157
[TBL] [Abstract][Full Text] [Related]
14. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
[TBL] [Abstract][Full Text] [Related]
15. Mucosal-associated invariant T (MAIT) cells, a new source of universal immune cells for chimeric antigen receptor (CAR)-cell therapy.
Bohineust A; Tourret M; Derivry L; Caillat-Zucman S
Bull Cancer; 2021 Oct; 108(10S):S92-S95. PubMed ID: 34920812
[TBL] [Abstract][Full Text] [Related]
16. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
[TBL] [Abstract][Full Text] [Related]
17. Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.
Sakala IG; Kjer-Nielsen L; Eickhoff CS; Wang X; Blazevic A; Liu L; Fairlie DP; Rossjohn J; McCluskey J; Fremont DH; Hansen TH; Hoft DF
J Immunol; 2015 Jul; 195(2):587-601. PubMed ID: 26063000
[TBL] [Abstract][Full Text] [Related]
18. Human liver CD8
Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC
J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824
[TBL] [Abstract][Full Text] [Related]
19. Conservation of mucosal associated invariant T (MAIT) cells and the MR1 restriction element in ruminants, and abundance of MAIT cells in spleen.
Goldfinch N; Reinink P; Connelley T; Koets A; Morrison I; Van Rhijn I
Vet Res; 2010; 41(5):62. PubMed ID: 20507818
[TBL] [Abstract][Full Text] [Related]
20. Mucosal-Associated Invariant T (MAIT) Cell Dysfunction and PD-1 Expression in Prostate Cancer: Implications for Immunotherapy.
Jarvis EM; Collings S; Authier-Hall A; Dasyam N; Luey B; Nacey J; Painter GF; Delahunt B; Hermans IF; Weinkove R
Front Immunol; 2021; 12():748741. PubMed ID: 34737749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]